Yersinia Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Test (Stool Culture, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy); Technique (PCR, DNA Probes, Monoclonal Antibodies, Immunoassay, IT, Others); End User (Hospital Laboratories, Public Health Laboratories, Commercial Laboratories)

Report Code: TIPRE00019694 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Yersinia is a rod-shaped, gram-positive bacterium in the Enterobacteriaceae family that causes enterocolitis, terminal iletis, mesenteric lymphadenitis, acute diarrhea, and sepsis. The pathogen species of Yersinia include Yersinia pestis, Yersinia enterocolitica, and Yersinia pseudotuberculosis. These species of Yersinia cause the Bubonic plague and gastroenteritis, respectively. The symptoms of the diseases caused by these bacteria include gastroenteritis, vomiting, abdominal pain, low-grade fever and diarrhea. The infection usually occurs in children. This infection affects men more often than women.

MARKET DYNAMICS

The yersinia diagnostics market is driving due to the high prevalence of Yersiniosis, emergence of improved diagnostic technologies such as molecular diagnostics and growing patient awareness levels across the globe. However, less knowledge regarding yersinia diagnostics may hinder the market's growth. Moreover, untapped opportunities in emerging Asian economies, focus on research and increase in research funding are expected to provide opportunities in the yersinia diagnostics market.

MARKET SCOPE

The "Yersinia diagnostics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of yersinia diagnostics market with detailed market segmentation by test, technique, and end user. The yersinia diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in yersinia diagnostics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The yersinia diagnostics market is segmented on the basis of test, technique, and end user. Based on test, the market is segmented as stool culture, ELISA, radioimmunoassay, tube agglutination, CT scan, ultrasonography, colonoscopy. Based on technique, the market is segmented as PCR, DNA probes, monoclonal antibodies, immunoassay, IT, others. Based on end user, the market is segmented as hospital laboratories, public health laboratories, commercial laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Yersinia diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The yersinia diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting yersinia diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Yersinia diagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the yersinia diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Yersinia diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for Yersinia diagnostics in the global market. Below mentioned is the list of few companies engaged in the Yersinia diagnostics market.

The report also includes the profiles of key players in yersinia diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Abbott
  •   Gen-probe
  •   Affymetrix Inc.
  •   Bio-Rad Laboratories
  •   Hologic
  •   Roche
  •   BD
  •   Danaher
  •   Thermo Fisher Scientific Inc.
  •   bioMérieux SA

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Yersinia Diagnostics Market - By Test
1.3.2 Yersinia Diagnostics Market - By Technique
1.3.3 Yersinia Diagnostics Market - By End User
1.3.4 Yersinia Diagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. YERSINIA DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. YERSINIA DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. YERSINIA DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. YERSINIA DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. YERSINIA DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. YERSINIA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TEST
7.1. OVERVIEW
7.2. TEST MARKET FORECASTS AND ANALYSIS
7.3. STOOL CULTURE
7.3.1. Overview
7.3.2. Stool Culture Market Forecast and Analysis
7.4. ELISA
7.4.1. Overview
7.4.2. ELISA Market Forecast and Analysis
7.5. RADIOIMMUNOASSAY
7.5.1. Overview
7.5.2. Radioimmunoassay Market Forecast and Analysis
7.6. TUBE AGGLUTINATION
7.6.1. Overview
7.6.2. Tube Agglutination Market Forecast and Analysis
7.7. CT SCAN
7.7.1. Overview
7.7.2. CT Scan Market Forecast and Analysis
7.8. ULTRASONOGRAPHY
7.8.1. Overview
7.8.2. Ultrasonography Market Forecast and Analysis
7.9. COLONOSCOPY
7.9.1. Overview
7.9.2. Colonoscopy Market Forecast and Analysis
8. YERSINIA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNIQUE
8.1. OVERVIEW
8.2. TECHNIQUE MARKET FORECASTS AND ANALYSIS
8.3. PCR
8.3.1. Overview
8.3.2. PCR Market Forecast and Analysis
8.4. DNA PROBES
8.4.1. Overview
8.4.2. DNA Probes Market Forecast and Analysis
8.5. MONOCLONAL ANTIBODIES
8.5.1. Overview
8.5.2. Monoclonal Antibodies Market Forecast and Analysis
8.6. IMMUNOASSAY
8.6.1. Overview
8.6.2. Immunoassay Market Forecast and Analysis
8.7. IT
8.7.1. Overview
8.7.2. IT Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. YERSINIA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL LABORATORIES
9.3.1. Overview
9.3.2. Hospital Laboratories Market Forecast and Analysis
9.4. PUBLIC HEALTH LABORATORIES
9.4.1. Overview
9.4.2. Public Health Laboratories Market Forecast and Analysis
9.5. COMMERCIAL LABORATORIES
9.5.1. Overview
9.5.2. Commercial Laboratories Market Forecast and Analysis
10. YERSINIA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Yersinia Diagnostics Market Overview
10.1.2 North America Yersinia Diagnostics Market Forecasts and Analysis
10.1.3 North America Yersinia Diagnostics Market Forecasts and Analysis - By Test
10.1.4 North America Yersinia Diagnostics Market Forecasts and Analysis - By Technique
10.1.5 North America Yersinia Diagnostics Market Forecasts and Analysis - By End User
10.1.6 North America Yersinia Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Yersinia Diagnostics Market
10.1.6.1.1 United States Yersinia Diagnostics Market by Test
10.1.6.1.2 United States Yersinia Diagnostics Market by Technique
10.1.6.1.3 United States Yersinia Diagnostics Market by End User
10.1.6.2 Canada Yersinia Diagnostics Market
10.1.6.2.1 Canada Yersinia Diagnostics Market by Test
10.1.6.2.2 Canada Yersinia Diagnostics Market by Technique
10.1.6.2.3 Canada Yersinia Diagnostics Market by End User
10.1.6.3 Mexico Yersinia Diagnostics Market
10.1.6.3.1 Mexico Yersinia Diagnostics Market by Test
10.1.6.3.2 Mexico Yersinia Diagnostics Market by Technique
10.1.6.3.3 Mexico Yersinia Diagnostics Market by End User
10.2. EUROPE
10.2.1 Europe Yersinia Diagnostics Market Overview
10.2.2 Europe Yersinia Diagnostics Market Forecasts and Analysis
10.2.3 Europe Yersinia Diagnostics Market Forecasts and Analysis - By Test
10.2.4 Europe Yersinia Diagnostics Market Forecasts and Analysis - By Technique
10.2.5 Europe Yersinia Diagnostics Market Forecasts and Analysis - By End User
10.2.6 Europe Yersinia Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Yersinia Diagnostics Market
10.2.6.1.1 Germany Yersinia Diagnostics Market by Test
10.2.6.1.2 Germany Yersinia Diagnostics Market by Technique
10.2.6.1.3 Germany Yersinia Diagnostics Market by End User
10.2.6.2 France Yersinia Diagnostics Market
10.2.6.2.1 France Yersinia Diagnostics Market by Test
10.2.6.2.2 France Yersinia Diagnostics Market by Technique
10.2.6.2.3 France Yersinia Diagnostics Market by End User
10.2.6.3 Italy Yersinia Diagnostics Market
10.2.6.3.1 Italy Yersinia Diagnostics Market by Test
10.2.6.3.2 Italy Yersinia Diagnostics Market by Technique
10.2.6.3.3 Italy Yersinia Diagnostics Market by End User
10.2.6.4 Spain Yersinia Diagnostics Market
10.2.6.4.1 Spain Yersinia Diagnostics Market by Test
10.2.6.4.2 Spain Yersinia Diagnostics Market by Technique
10.2.6.4.3 Spain Yersinia Diagnostics Market by End User
10.2.6.5 United Kingdom Yersinia Diagnostics Market
10.2.6.5.1 United Kingdom Yersinia Diagnostics Market by Test
10.2.6.5.2 United Kingdom Yersinia Diagnostics Market by Technique
10.2.6.5.3 United Kingdom Yersinia Diagnostics Market by End User
10.2.6.6 Rest of Europe Yersinia Diagnostics Market
10.2.6.6.1 Rest of Europe Yersinia Diagnostics Market by Test
10.2.6.6.2 Rest of Europe Yersinia Diagnostics Market by Technique
10.2.6.6.3 Rest of Europe Yersinia Diagnostics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Yersinia Diagnostics Market Overview
10.3.2 Asia-Pacific Yersinia Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Yersinia Diagnostics Market Forecasts and Analysis - By Test
10.3.4 Asia-Pacific Yersinia Diagnostics Market Forecasts and Analysis - By Technique
10.3.5 Asia-Pacific Yersinia Diagnostics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Yersinia Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Yersinia Diagnostics Market
10.3.6.1.1 Australia Yersinia Diagnostics Market by Test
10.3.6.1.2 Australia Yersinia Diagnostics Market by Technique
10.3.6.1.3 Australia Yersinia Diagnostics Market by End User
10.3.6.2 China Yersinia Diagnostics Market
10.3.6.2.1 China Yersinia Diagnostics Market by Test
10.3.6.2.2 China Yersinia Diagnostics Market by Technique
10.3.6.2.3 China Yersinia Diagnostics Market by End User
10.3.6.3 India Yersinia Diagnostics Market
10.3.6.3.1 India Yersinia Diagnostics Market by Test
10.3.6.3.2 India Yersinia Diagnostics Market by Technique
10.3.6.3.3 India Yersinia Diagnostics Market by End User
10.3.6.4 Japan Yersinia Diagnostics Market
10.3.6.4.1 Japan Yersinia Diagnostics Market by Test
10.3.6.4.2 Japan Yersinia Diagnostics Market by Technique
10.3.6.4.3 Japan Yersinia Diagnostics Market by End User
10.3.6.5 South Korea Yersinia Diagnostics Market
10.3.6.5.1 South Korea Yersinia Diagnostics Market by Test
10.3.6.5.2 South Korea Yersinia Diagnostics Market by Technique
10.3.6.5.3 South Korea Yersinia Diagnostics Market by End User
10.3.6.6 Rest of Asia-Pacific Yersinia Diagnostics Market
10.3.6.6.1 Rest of Asia-Pacific Yersinia Diagnostics Market by Test
10.3.6.6.2 Rest of Asia-Pacific Yersinia Diagnostics Market by Technique
10.3.6.6.3 Rest of Asia-Pacific Yersinia Diagnostics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Yersinia Diagnostics Market Overview
10.4.2 Middle East and Africa Yersinia Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Yersinia Diagnostics Market Forecasts and Analysis - By Test
10.4.4 Middle East and Africa Yersinia Diagnostics Market Forecasts and Analysis - By Technique
10.4.5 Middle East and Africa Yersinia Diagnostics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Yersinia Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Yersinia Diagnostics Market
10.4.6.1.1 South Africa Yersinia Diagnostics Market by Test
10.4.6.1.2 South Africa Yersinia Diagnostics Market by Technique
10.4.6.1.3 South Africa Yersinia Diagnostics Market by End User
10.4.6.2 Saudi Arabia Yersinia Diagnostics Market
10.4.6.2.1 Saudi Arabia Yersinia Diagnostics Market by Test
10.4.6.2.2 Saudi Arabia Yersinia Diagnostics Market by Technique
10.4.6.2.3 Saudi Arabia Yersinia Diagnostics Market by End User
10.4.6.3 U.A.E Yersinia Diagnostics Market
10.4.6.3.1 U.A.E Yersinia Diagnostics Market by Test
10.4.6.3.2 U.A.E Yersinia Diagnostics Market by Technique
10.4.6.3.3 U.A.E Yersinia Diagnostics Market by End User
10.4.6.4 Rest of Middle East and Africa Yersinia Diagnostics Market
10.4.6.4.1 Rest of Middle East and Africa Yersinia Diagnostics Market by Test
10.4.6.4.2 Rest of Middle East and Africa Yersinia Diagnostics Market by Technique
10.4.6.4.3 Rest of Middle East and Africa Yersinia Diagnostics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Yersinia Diagnostics Market Overview
10.5.2 South and Central America Yersinia Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America Yersinia Diagnostics Market Forecasts and Analysis - By Test
10.5.4 South and Central America Yersinia Diagnostics Market Forecasts and Analysis - By Technique
10.5.5 South and Central America Yersinia Diagnostics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Yersinia Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Yersinia Diagnostics Market
10.5.6.1.1 Brazil Yersinia Diagnostics Market by Test
10.5.6.1.2 Brazil Yersinia Diagnostics Market by Technique
10.5.6.1.3 Brazil Yersinia Diagnostics Market by End User
10.5.6.2 Argentina Yersinia Diagnostics Market
10.5.6.2.1 Argentina Yersinia Diagnostics Market by Test
10.5.6.2.2 Argentina Yersinia Diagnostics Market by Technique
10.5.6.2.3 Argentina Yersinia Diagnostics Market by End User
10.5.6.3 Rest of South and Central America Yersinia Diagnostics Market
10.5.6.3.1 Rest of South and Central America Yersinia Diagnostics Market by Test
10.5.6.3.2 Rest of South and Central America Yersinia Diagnostics Market by Technique
10.5.6.3.3 Rest of South and Central America Yersinia Diagnostics Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL YERSINIA DIAGNOSTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. YERSINIA DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GEN-PROBE
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AFFYMETRIX INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIO-RAD LABORATORIES
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. HOLOGIC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ROCHE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BD
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DANAHER
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. THERMO FISHER SCIENTIFIC INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIOMéRIEUX SA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Gen-probe
3. Affymetrix Inc.
4. Bio-Rad Laboratories
5. Hologic
6. Roche
7. BD
8. Danaher
9. Thermo Fisher Scientific Inc.
10. bioMérieux SA
TIPRE00019694
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking